A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer

Por Chawla, Sant P., Bruckner, Howard, Morse, Michael A., Assudani, Nupur, Hall, Frederick L., Gordon, Erlinda M.
Publicado no Mol Ther Oncolytics (2018)